What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.26%Below 5Y avg (2.73%)
Annual Rate
CNY 0.37Paid annual
Payout Ratio
48.3%Sustainable
Payback Period
43.5 yr
Last Ex-Dividend
May 26, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
54.47BCNY
8.08B · vs all stocks (USD)
Updated Aug 19, 2026
Trailing P/E
14.49x
Updated Aug 19, 2026
Revenue (TTM)
34.27BCNY
5.08B · vs all stocks (USD)
Updated Aug 19, 2026
Profit Margin
10.99%
Updated Aug 19, 2026
Beta
0.6250x
vs all stocks
Updated Aug 19, 2026
52-Week Change
-10.64%
vs all stocks
Updated Aug 19, 2026
Market Capitalization
54.47BCNY
8.08B · vs all stocks (USD)
Updated Aug 19, 2026
Enterprise Value
46.16BCNY
6.85B · vs all stocks (USD)
Updated Aug 19, 2026
Trailing P/E
14.49x
Updated Aug 19, 2026
Forward P/E
13.22x
Updated Aug 19, 2026
Price to Sales (TTM)
1.59x
Updated Aug 19, 2026
Price to Book (MRQ)
1.39x
Updated Aug 19, 2026
Enterprise to Revenue
1.35x
Updated Aug 19, 2026
Enterprise to EBITDA
12.10x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 10.66×.Updated Aug 19, 2026
Gross Margin
43.77%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 40.94%.Updated Aug 19, 2026
Profit Margin
10.99%
Updated Aug 19, 2026
Operating Margin
14.80%
Updated Aug 19, 2026
Return on Assets (TTM)
3.74%
Updated Aug 19, 2026
Return on Equity (TTM)
9.59%
Updated Aug 19, 2026
Revenue (TTM)
34.27BCNY
5.08B · vs all stocks (USD)
Updated Aug 19, 2026
Revenue per Share (TTM)
10.47CNYUpdated Aug 19, 2026
Quarterly Revenue Growth
9.80%
Updated Aug 19, 2026
Gross Profit (TTM)
14.03BCNY
2.08B · vs all stocks (USD)
Updated Aug 19, 2026
EBITDA (TTM)
4.33BCNY
642.38M · vs all stocks (USD)
Updated Aug 19, 2026
Net Income (TTM)
3.77BCNY
558.40M · vs all stocks (USD)
Updated Aug 19, 2026
Quarterly Earnings Growth (YoY)
-7.50%
Updated Aug 19, 2026
Operating Cash Flow (TTM)
2.16BCNY
320.54M · vs all stocks (USD)
Updated Aug 19, 2026
Levered Free Cash Flow (TTM)
490.39MCNY
72.73M · vs all stocks (USD)
Updated Aug 19, 2026
Trailing Annual Dividend Rate
0.3700CNYUpdated Aug 19, 2026
Trailing Annual Dividend Yield
2.26%
vs all stocks
Updated Aug 19, 2026
5-Year Average Dividend Yield
2.73%
vs all stocks
Updated Aug 19, 2026
Payout Ratio
48.26%
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 32.17%.Updated Aug 19, 2026
Minority Interest (Equity)
716.98MCNYFY2025 · Dec 31, 2025
Revenue
32.74BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
19.44BCNYFY2025 · Dec 31, 2025
Gross Profit
13.30BCNYFY2025 · Dec 31, 2025
Operating Income
3.42BCNY
507.75M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
4.36BCNYFY2025 · Dec 31, 2025
Income Tax Expense
480.34MCNYFY2025 · Dec 31, 2025
Net Income
3.88BCNYFY2025 · Dec 31, 2025
EBIT
4.34BCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
5.24BCNYFY2025 · Dec 31, 2025
Research & Development
4.34BCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
1.76BCNYFY2025 · Dec 31, 2025
Other Operating Expenses
261.33MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
281.63MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
-21.98MCNYFY2025 · Dec 31, 2025
EPS (Basic)
1.18CNYFY2025 · Dec 31, 2025
EPS (Diluted)
1.18CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
3.27BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
3.27BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
3.88BCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-24.33MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
3.45BCNYFY2025 · Dec 31, 2025
Free Cash Flow
2.78BCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
8.55BCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
3.88BCNYFY2025 · Dec 31, 2025
Other Non-cash Items
2.19MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
600.35MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-1.03BCNYFY2025 · Dec 31, 2025
Capital Expenditures
-668.36MCNYFY2025 · Dec 31, 2025
Net Acquisitions
273.93MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-16.64BCNYFY2025 · Dec 31, 2025
Sale of Investments
13.94BCNYFY2025 · Dec 31, 2025
Other Investing Activity
-1.63MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-3.09BCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
904.66MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-1.70BCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-2.10BCNYFY2025 · Dec 31, 2025
Other Financing Charges
-469.70MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-3.36BCNYFY2025 · Dec 31, 2025
Shares Outstanding
3.29BSharesUpdated Aug 19, 2026
Float Shares
1.64BSharesUpdated Aug 19, 2026
% Held by Insiders
48.93%
vs all stocks
Updated Aug 19, 2026
% Held by Institutions
8.99%
vs all stocks
Updated Aug 19, 2026
Total Cash (MRQ)
12.11BCNY
1.80B · vs all stocks (USD)
Updated Aug 19, 2026
Total Cash per Share (MRQ)
3.70CNYUpdated Aug 19, 2026
Total Debt (MRQ)
2.92BCNY
432.83M · vs all stocks (USD)
Updated Aug 19, 2026
Total Debt to Equity (MRQ)
0.0730x
Updated Aug 19, 2026
Current Ratio (MRQ)
2.68x
Updated Aug 19, 2026
Book Value per Share (MRQ)
11.96CNYUpdated Aug 19, 2026
Total Assets
52.56BCNY
7.79B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
34.25BCNYFY2025 · Dec 31, 2025
Total Liabilities
14.08BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
18.30BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
651.61MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
13.43BCNYFY2025 · Dec 31, 2025
Cash
8.55BCNYFY2025 · Dec 31, 2025
Cash Equivalents
107.55MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
8.66BCNYFY2025 · Dec 31, 2025
Other Short-term Investments
309.16MCNYFY2025 · Dec 31, 2025
Accounts Receivable
15.47BCNYFY2025 · Dec 31, 2025
Inventory
6.09BCNYFY2025 · Dec 31, 2025
Accounts Payable
8.79BCNYFY2025 · Dec 31, 2025
Short-term Debt
450.57MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
167.75MCNYFY2025 · Dec 31, 2025
Long-term Debt
165.40MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
257.44MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
3.29BCNYFY2025 · Dec 31, 2025
Retained Earnings
26.18BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
38.47BCNY
5.71B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
709.08MCNYFY2025 · Dec 31, 2025
52-Week Low
15.78CNYUpdated Aug 19, 2026
52-Week High
21.96CNYUpdated Aug 19, 2026
52-Week Change
-10.64%
vs all stocks
Updated Aug 19, 2026
Beta
0.6250x
vs all stocks
Updated Aug 19, 2026
50-Day MA
16.52CNYUpdated Aug 19, 2026
200-Day MA
18.06CNYUpdated Aug 19, 2026
Avg 10-Day Volume
40.80MSharesUpdated Aug 19, 2026
Avg 30-Day Volume
45.44MSharesUpdated Aug 19, 2026
Diluted EPS (TTM)
1.15CNYUpdated Aug 19, 2026
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 4.39: safe zoneNotable
Altman Z-Score: 4.39
Supply Chain
Upstream position: supplies 6 industries, depends on 1Notable
Outgoing: 6.00Incoming: 1.00
Scale
Market cap is $8.08B, above the global median of $1.15BNotable
Market cap (USD): 8,077,293,882.342Global Median: 1,146,734,693.424
Revenue is $5.08B, above the global median of $520.53MNotable
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityLow-Leverage Liquidity Configuration
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityLow-Leverage Liquidity Configuration
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityLow-Leverage Liquidity Configuration